Over a year after Pear Therapeutics filed for bankruptcy and shut down, its smartphone apps for people with substance use disorder and opioid use disorder are again available to patients.
After acquiring Pear’s Food and Drug Administration-cleared apps, called reSET and reSET-O, in December 2023, virtual addiction treatment company PursueCare this month began offering them to its patients. The company will use the apps to complement its care plans as it develops business opportunities around the treatments.
PursueCare’s approach to the relaunch reflects the growing pragmatism among companies hoping to bring prescription digital treatments for psychiatric and other conditions to market. As standalone offerings, these digital therapeutics have struggled to gain adoption by insurers, clinicians, and patients. Increasingly, companies are looking to use apps to support existing care and business models, rather than marketing them as standalone products.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
